ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough proprietary technology platform for scalable, high-throughput tissue generation.

Our team brings highly relevant experience from the biotech industry and expertise in cell biology, tissue culture automation, and translational research from top academic institutions across Europe and the US.